Effect of Birth on Immunological Parameters in Cord Blood
To Investigate the Immediate Effect of Birth on Immunological Parameters in Cord Blood, and Compare With Data of CS Born Infants Collected in the JULIUS SN Study
Sponsor: Danone Asia Pacific Holdings Pte, Ltd.
Listed as NCT03134768, this observational or N/A phase trial focuses on Immunologic Activity Alteration and remains completed. Sponsored by Danone Asia Pacific Holdings Pte, Ltd., it has been updated 15 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Dec 2021 — Dec 2022 [monthly]
Completed
▶ Show 10 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
May 2020 — Nov 2020 [monthly]
Completed
-
Apr 2020 — May 2020 [monthly]
Completed
-
Aug 2018 — Apr 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Danone Asia Pacific Holdings Pte, Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.